Buscar
OraSure Technologies Inc
OSURAñadir a la lista de seguimiento
3.980USD
-0.040-1.00%
Cierre 07-29 16:00（ET）Cotizaciones retrasadas 15 min
276.20MCap. mercado
PérdidaP/E TTM
Más Datos de OraSure Technologies Inc Compañía
OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company improves the access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers. Its products and services include OraQuick ADVANCE Rapid HIV1/2 Antibody Test, OraQuick HIV Self-Test, and Diagnostics Direct Syphilis Health Check.
Información de OraSure Technologies Inc
Símbolo de cotizaciónOSUR
Nombre de la empresaOraSure Technologies Inc
Fecha de salida a bolsaNov 17, 1986
Director ejecutivoEglinton Manner (Carrie)
Número de empleados501
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 17
Dirección220 E First St
CiudadBETHLEHEM
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal18015
Teléfono15036416115
Sitio Webhttps://www.orasure.com/
Símbolo de cotizaciónOSUR
Fecha de salida a bolsaNov 17, 1986
Director ejecutivoEglinton Manner (Carrie)
Ejecutivos de OraSure Technologies Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kenneth J. (Ken) Mcgrath
Mr. Kenneth J. (Ken) Mcgrath
Chief Financial Officer
Chief Financial Officer
589.56K
--
Mr. John P. Kenny
Mr. John P. Kenny
Independent Chairman of the Board
Independent Chairman of the Board
209.71K
+21.99%
Dr. Nancy J. Gagliano, M.D.
Dr. Nancy J. Gagliano, M.D.
Independent Director
Independent Director
185.06K
+24.91%
Mr. Lelio Marmora
Mr. Lelio Marmora
Independent Director
Independent Director
148.46K
+31.06%
Hon Dr. David J. Shulkin, M.D.
Hon Dr. David J. Shulkin, M.D.
Independent Director
Independent Director
126.33K
+52.26%
Ms. Carrie Eglinton Manner
Ms. Carrie Eglinton Manner
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Jason Plagman
Mr. Jason Plagman
Vice President - Investor Relations
Vice President - Investor Relations
--
--
Mr. Robert W. Mcmahon
Mr. Robert W. Mcmahon
Independent Director
Independent Director
--
--
Ms. Anne Messing
Ms. Anne Messing
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Steven K. (Steve) Boyd
Mr. Steven K. (Steve) Boyd
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kenneth J. (Ken) Mcgrath
Mr. Kenneth J. (Ken) Mcgrath
Chief Financial Officer
Chief Financial Officer
589.56K
--
Mr. John P. Kenny
Mr. John P. Kenny
Independent Chairman of the Board
Independent Chairman of the Board
209.71K
+21.99%
Dr. Nancy J. Gagliano, M.D.
Dr. Nancy J. Gagliano, M.D.
Independent Director
Independent Director
185.06K
+24.91%
Mr. Lelio Marmora
Mr. Lelio Marmora
Independent Director
Independent Director
148.46K
+31.06%
Hon Dr. David J. Shulkin, M.D.
Hon Dr. David J. Shulkin, M.D.
Independent Director
Independent Director
126.33K
+52.26%
Ms. Carrie Eglinton Manner
Ms. Carrie Eglinton Manner
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de OraSure Technologies Inc?
Los cinco principales accionistas de OraSure Technologies Inc son: Mr. Kenneth J. (Ken) Mcgrath
¿Cuántas instituciones poseen acciones de OraSure Technologies Inc (OSUR)?
A fecha de 2026Q1, 436 instituciones poseen acciones de OraSure Technologies Inc, con un valor de mercado combinado de aproximadamente 65.49M, lo que representa el 91.21% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -10065967.00.
¿Cuál es la mayor fuente de ganancias de OraSure Technologies Inc?
El 2026Q1, el segmento empresarial Net product and services revenues - HIV generó la ganancia más alta para OraSure Technologies Inc, ascendiendo a 49.80M y representando el 43.30% de la ganancia total.